In recent decades, the advent of immune-based therapies, most notably Chimeric antigen
receptor (CAR)-T cell therapy has revolutionized cancer treatment. The promising results of …

Novel therapeutic agents in clinical trials offer a paradigm shift in the approach to battling
this prevalent and destructive disease, and the area of cancer therapy is on the precipice of …

For many years, the methods of cancer treatment are usually surgery, chemotherapy and
radiation therapy. Although these methods help to improve the condition, most tumors still …

In the last twenty years, we have witnessed a paradigm shift in the treatment and prognosis
of acute myeloid leukemia (AML), thanks to the introduction of new efficient drugs or …

Hepatocellular carcinoma (HCC) remains a global health challenge that urgently calls for
innovative therapeutic strategies. Chimeric antigen receptor T cell (CAR T) therapy has …

Colorectal cancer (CRC) is a major contributor to global cancer incidence and mortality.
Conventional treatments have limitations; hence, innovative approaches are imperative …

Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary development in the field of
cancer immunotherapy, offering a targeted approach to combat various hematologic …

Cell surface engineering with exogeneous receptors holds great promise for various
applications. However, current biological methods face problems with safety, antigen …

Introduction Neoplastic meningitis (NM), also known as leptomeningeal carcinomatosis, is
characterized by the infiltration of tumor cells into the meninges, and poses a significant …

Background: Chimeric antigen receptor (CAR) T cell therapy has shown significant promise
in treating hematological malignancies, yet its application in solid tumors, particularly those …